Targeted Downregulation of kdm4a Ameliorates Tau-engendered Defects in Drosophila melanogaster.

CONCLUSION: Our results suggest that downregulation of kdm4a expression may be a potential therapeutic target in AD. PMID: 31436053 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31436053?dopt=Abstract

Source: J Korean Med Sci - August 23, 2019 Category: General Medicine Authors: Park SY, Seo J, Chun YS Tags: J Korean Med Sci Source Type: research